The MISSION of the MND Association is to fund research aimed at increasing treatment options and improving the clinical and healthcare practice for Amyotrophic Lateral Sclerosis (ALS) and related conditions. This effort supports not only people living with MND but also caregivers and families, focusing on research that informs and expands the NICE Guideline for Motor Neurone Disease through identifying knowledge gaps and generating a robust evidence base to strengthen the case for high-quality MND care funding.
The Healthcare Project Grants provided by the MND Association are designed to support single projects that seek to answer specific questions or a small group of related questions about Amyotrophic Lateral Sclerosis (ALS) and related conditions. These projects should aim to increase treatment options and improve clinical and healthcare practice. The grants typically support research of limited duration, with applications for up to three years considered. Shorter projects, especially those less than two years, should ideally include a named researcher with relevant expertise. The continuation of support for a project is contingent on an annual review following the submission of a progress report at the end of each year. Funding limits are set at £80,000 per annum (£240,000 in total) for non-London Institutes and £85,000 per annum (£255,000 in total) for London Institutes, barring prior agreement from the MND Association. This program emphasizes working in conjunction with established research institutions like universities and hospitals.